search
Back to results

Feasibility Study of Exercise in Patients With Leg Blood Clots (EXPERT)

Primary Purpose

Deep Vein Thrombosis

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise
Sponsored by
University of Oklahoma
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Deep Vein Thrombosis focused on measuring Lower extremity DVT, Clot, leg clot, Deep vein thrombosis, Thrombosis, Warfarin

Eligibility Criteria

21 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • First episode lower extremity DVT (proximal or distal) documented by ultrasound, CT angiogram or venogram within last 4 weeks.
  • Treatment with LMWH, or unfractionated heparin (UFH) followed by warfarin adjusted to keep INR 2 to 3 for at least 3 months, or LMWH given in therapeutic doses as sole therapy.
  • Age 21 to 75 years old.

Exclusion Criteria:

  • Recurrent DVT.
  • Treatment of DVT with systemic or catheter-directed thrombolysis Contraindications to exercise training according to the American College of Sports Medicine (e.g., acute myocardial infarction, unstable angina, etc.,).
  • Life expectancy < 1 year.
  • Pregnancy.
  • Geographic inaccessibility.
  • Screening (pre-randomization) exercise stress test demonstrating contraindication to exercise training (see exclusion #2).
  • Cognitive dysfunction assessed by mini-mental status exam (score < 24).
  • Inability to walk.

Sites / Locations

  • University of Oklahoma Health Sciences Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Exercise testing

Arm Description

Feasibility study; all participants receive intervention

Outcomes

Primary Outcome Measures

Villalta PTS score

Secondary Outcome Measures

PTS, venous valvular reflux, VEINES, MOS SF-36, maximal treadmill test, 6-minute walk, and blood analysis

Full Information

First Posted
May 28, 2009
Last Updated
April 11, 2017
Sponsor
University of Oklahoma
search

1. Study Identification

Unique Protocol Identification Number
NCT00910364
Brief Title
Feasibility Study of Exercise in Patients With Leg Blood Clots
Acronym
EXPERT
Official Title
EXPERT Trial: Exercise to Prevent Post-thrombotic Syndrome Elicited by Recent Thrombosis
Study Type
Interventional

2. Study Status

Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
October 2008 (undefined)
Primary Completion Date
December 2012 (Actual)
Study Completion Date
December 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Oklahoma

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this pilot study is to assess the feasibility of determining the effects of a structured exercise program started two to four weeks after diagnosis of a first episode lower-extremity deep vein thrombosis (DVT) for a period of 12 weeks in reducing the incidence of post-thrombotic syndrome (PTS).
Detailed Description
Deep Vein Thrombosis (DVT) affects nearly 300,000 people in the U.S. each year. DVT of the leg results in PTS in up to 65% of patients,despite receiving appropriate medical management with anticoagulant therapy. PTS, caused by persistent venous outflow obstruction and venous valvular dysfunction, may result in symptoms of leg pain, swelling, heaviness and cramping especially with prolonged standing. All eligible patients with documented first-episode DVT interested in participating will undergo medical screening and a screening treadmill test prior to enrollment between two and four weeks post DVT diagnosis. All patients will be provided and asked to wear class II (30 to 40mmHg) knee length compression hose daily during the entire trial. The formal exercise training includes both a supervised walking program and a home-based walking program for 12 weeks with follow-up at 26 weeks. Blood tests will be taken to measure levels of indicators of inflammation at baseline, week 4, week 12, and week 26. The primary outcomes will be the feasibility of the exercise program and the incidence of post-thrombotic syndrome at 26 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Deep Vein Thrombosis
Keywords
Lower extremity DVT, Clot, leg clot, Deep vein thrombosis, Thrombosis, Warfarin

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
5 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Exercise testing
Arm Type
Experimental
Arm Description
Feasibility study; all participants receive intervention
Intervention Type
Other
Intervention Name(s)
Exercise
Intervention Description
Exercise
Primary Outcome Measure Information:
Title
Villalta PTS score
Time Frame
at 26 weeks
Secondary Outcome Measure Information:
Title
PTS, venous valvular reflux, VEINES, MOS SF-36, maximal treadmill test, 6-minute walk, and blood analysis
Time Frame
at 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: First episode lower extremity DVT (proximal or distal) documented by ultrasound, CT angiogram or venogram within last 4 weeks. Treatment with LMWH, or unfractionated heparin (UFH) followed by warfarin adjusted to keep INR 2 to 3 for at least 3 months, or LMWH given in therapeutic doses as sole therapy. Age 21 to 75 years old. Exclusion Criteria: Recurrent DVT. Treatment of DVT with systemic or catheter-directed thrombolysis Contraindications to exercise training according to the American College of Sports Medicine (e.g., acute myocardial infarction, unstable angina, etc.,). Life expectancy < 1 year. Pregnancy. Geographic inaccessibility. Screening (pre-randomization) exercise stress test demonstrating contraindication to exercise training (see exclusion #2). Cognitive dysfunction assessed by mini-mental status exam (score < 24). Inability to walk.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Suman W. Rathbun, M.D.
Organizational Affiliation
Oklahoma University Health Sciences Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Oklahoma Health Sciences Center
City
Oklahoma city
State/Province
Oklahoma
ZIP/Postal Code
73104
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Feasibility Study of Exercise in Patients With Leg Blood Clots

We'll reach out to this number within 24 hrs